Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.

Pecher AC, Henes J, Henes M, Lengerke C, Bethge W, Wirsching A, Rothe T, Müller F, Mackensen A, Schett G, Hagen M

Open source

DOI
10.1093/rheumatology/keag413
Published
2026 Aug 1
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag413,
  title = {Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.},
  author = {Pecher AC and Henes J and Henes M and Lengerke C and Bethge W and Wirsching A and Rothe T and Müller F and Mackensen A and Schett G and Hagen M},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag413},
  url = {https://doi.org/10.1093/rheumatology/keag413}
}

RIS

TY  - JOUR
TI  - Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.
AU  - Pecher AC
AU  - Henes J
AU  - Henes M
AU  - Lengerke C
AU  - Bethge W
AU  - Wirsching A
AU  - Rothe T
AU  - Müller F
AU  - Mackensen A
AU  - Schett G
AU  - Hagen M
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag413
UR  - https://doi.org/10.1093/rheumatology/keag413
ER  - 

APA

AC, P., J, H., M, H., C, L., W, B., A, W., T, R., F, M., A, M., G, S., & M, H. (2026). Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag413

Source records